Ignite Creation Date:
2024-05-06 @ 7:50 PM
Last Modification Date:
2024-10-26 @ 3:15 PM
Study NCT ID:
NCT06153498
Status:
RECRUITING
Last Update Posted:
2023-12-13
First Post:
2023-11-23
Brief Title:
PKPD Properties and Safety of Remazolam Besylate for Injection in ICU Patients With Impaired Renal Function
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Organization Data
Organization:
Wuhan Union Hospital China
Class:
OTHER
Study ID:
WHUICU202203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wuhan Union Hospital China
Lead Sponsor Class:
OTHER
Responsible Party:
Xiaobo Yang MD
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Wuhan Union Hospital China
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Yichang Humanwell Pharmaceutical Co Ltd China | INDUSTRY |